spinal muscular atrophy Archives

Novartis axed Avexis execs ahead of Zolgensma scandal

https://pharmaphorum.com/news/novartis-axed-avexis-execs-ahead-of-zolgensma-scandal/

US senators blast Novartis for Zolgensma data falsification

https://pharmaphorum.com/news/us-senators-blast-novartis-for-zolgensma-data-falsification/

Second death in gene therapy trial prompts investigation

https://pharmaphorum.com/news/second-death-in-novartis-gene-therapy-trial-prompts-investigation/

PTC shares soar after SMA drug data impresses market

https://pharmaphorum.com/news/ptc-therapeutics-posts-solid-sma-data/

Biogen courts controversy with $750k-a-year rare disease drug

https://pharmaphorum.com/news/biogen-controversy/

Biogen names new CEO

https://pharmaphorum.com/news/biogen-names-new-ceo/

Biogen to file spinal muscular atrophy drug

https://pharmaphorum.com/news/biogen-file-spinal-muscular-atrophy-drug/

Search